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Background: Equity in access to health care among people living with HIV (PLHA) has not been extensively
studied in Peru despite the fact there is significant social diversity within this group. We aimed to assess the extent
to which health care provision to PLHA, including ARVT, was equitable and, if appropriate, identify factors
associated with lower access.
Methods: We conducted a survey among adult PLHA in four cities in Peru, recruited through respondent-driven
sampling (RDS), to collect information on socio-demographic characteristics, social network size, household welfare,
economic activity, use of HIV-related services including ARV treatment, and health-related out-of-pocket expenses.
Results: Between September 2008 and January 2009, 863 individuals from PLHA organizations in four cities of Peru
were enrolled. Median age was 35 (IQR = 29–41), and mostly male (62%). Overall, 25% reported to be gay, 11%
bisexual and 3% transgender. Most PLHA (96%) reported access to some kind of HIV-related health service, and 84%
were receiving those services at a public facility. Approximately 85% of those reporting access to care were
receiving antiretroviral treatment (ARV), and 17% of those not in treatment already had indication to start
treatment. Among those currently on ARV, 36% percent reported out-of-pocket expenses within the last month.
Transgender identity and age younger than 35 years old, were associated with lower access to health care.
Conclusions: Our findings contribute to a better social and demographic characterization of the situation of PLHAs,
their access to HIV care and their source of care, and provide an assessment of equity in access. In the long term, it
is expected that HIV care access, as well as its social determinants, will impact on the morbidity and mortality rates
among those affected by the HIV/AIDS epidemic. HIV care providers and program managers should further
characterize the barriers to healthcare access and develop strategies to resolve them by means of policy change,
for the benefit of the health service users and as part of the national response to the HIV/AIDS epidemic within a
human rights framework.
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The concept of social determinants of health (SDH)
has been defined broadly as encompassing the full
set of social conditions in which people grow, live,
work and age [1]. SDH operate at different causal
levels such as socioeconomic context, exposure, vul-
nerability, access to health care, health outcomes and
consequences, and can be identified and addressed
at those levels [2]. However, despite this need, there
is a lack of appropriate SDH and disease outcome* Correspondence: alfonsoss@upch.pe
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distribution, and reproduction in any mediumanalyses to quantify the contribution of SDH vari-
ables to specific outcomes of interest, such as health
access [3].
In this line of thinking, since early in the epidemic,
the HIV field has been enriched by the analysis of
social determinants of HIV acquisition and disease
progression, usually showing that HIV incidence and
disease outcomes are related to the social position
an individual occupies in the social gradient [4].
Monitoring the prevalence of those factors and their indi-
vidual contributions to health outcomes has proved im-
portant in understanding not only disease incidence and
critical preventive interventions, but also access tod Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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can be improved [5]. Unfortunately, as current evidence
supports, there is a paucity of studies on the SDH of access
and adherence to antiretroviral therapy, especially in Latin
American countries [6].
After the contrasting conditions of access to HIV
treatment between the global North and the global
South became more evident towards the end of the
1990’s, key initiatives were taken to improve HIV care
access in lower and middle-income countries. In June
2001, the United Nations General Assembly Special
Session on HIV (UNGASS) set timeline goals to be
reached according to commitments among govern-
ments, civil society and the private sector across the
nations involved [7]. Those are based on the HIV Dec-
laration of Commitment (DoC) on HIV/AIDS adopted
by all United Nations member states. Recent evidence
indicates continued progress in scaling up antiretroviral
treatment, with global coverage increasing by 36 per
cent in 2008 alone [8].
Over the past 25 years, the government of Peru, orga-
nized civil society groups, and academic institutions,
have developed multiple collaborative efforts to fight the
HIV/AIDS epidemic [9,10]. Those efforts were boosted
in the past 8 years with support from the Global Fund
to fight AIDS, Tuberculosis and Malaria (GFATM) that,
among other things, helped to launch the National
Antiretroviral Treatment Program which started free-of
-cost antiretroviral treatment provision at government-
administered health facilities [9,11]. Currently, the
existing Peruvian health care providers, Ministry of
Health (MoH), Social Security (ESSALUD), HIV Com-
mittee for Uniformed Institutions; and private sector
systems, offer specialized service to people living with
HIV/AIDS (PLHA) including: diagnosis, counseling, pre-
vention and prophylaxis of opportunistic infections; and
antiretroviral treatment (ARVT), including clinical, viral
and immunological monitoring prior to and during such
treatment. Most existing services were initially
implemented as part of the activities sponsored by
GFATM, but most of them are now government-funded
[12]. However, the sole existence of such health services
does not necessarily warrant their success. Current evi-
dence shows that, in 2009, 12,473 PLHA were treated at
MoH centers, covering an estimated 75% of clients regis-
tered in the National HIV Care Program [11]. This fig-
ure did not take into account PLHA receiving care from
other health providers.
As part of the evaluation of HIV projects implemented
under Global Fund support, a few studies have focused
on access to HIV treatment and care among PLHA in
Peru [13-16]. Those studies, however, were rapid assess-
ments among clients recruited in HIV care facilities;
hence potentially overestimating treatment coverage.Nevertheless, without a sampling framework for this
population, particularly in the context of stigma, better
sampling schemes were not available limited. In recent
years methods such as respondent-driven sampling
(RDS), based on social networks, have become increas-
ingly popular to reach hidden populations [17]. While
factors linking other hidden social networks (e.g. social
and sexual interaction among men who have sex with
men, socialization and equipment sharing among injec-
tion drug users) are not necessarily present among
PLHA and some of them may in fact prefer isolation
due to fear of rejection and abandonment [18], since
early in the Peruvian epidemic self-support groups and
community-based organizations promoted networking.
On that basis, we used RDS to assemble a sample of
PLHA from five cities in Peru, with the goal of assessing
HIV-related health care access, and exploring the rela-
tionship between such access and key socio-
demographic and socio-economic determinants. Add-
itionally, we explored the relationship between entitle-
ment to specific sources of health care and effective
utilization of those sources for HIV care.Methods
Study design, enrollment
A population-based cross-sectional study targeting indi-
viduals 18 years or older with a known HIV diagnosis
was conducted in 5 Peruvian cities: Lima and Callao
(considered as a single metropolitan area), Chiclayo
(in the Northern coast), Arequipa (in the highlands) and
Iquitos (in Amazonia) between January and July 2009. Par-
ticipants were reached and recruited through respondent-
driven sampling (RDS), which has been extensively used
for biological and behavioral surveillance in hard-to-reach
populations [17,19]. Briefly, an initial group of 7 “seeds”,
who were members of PLHA organizations in each of
those 4 metropolitan areas were invited to participate and,
if accepting, were instructed to refer other PLHAs they
knew, who might or might not be affiliated to their organi-
zations. Selected seeds belonged to PLHA organizations in
each of those 4 metropolitan areas. In turn, each referred
participant was asked to invite three other PLHA of their
personal social networks, repeating this referral cycle as
many times as needed until reaching the desired sample
size. Eligibility criteria included having a known HIV diag-
nosis, being older than 18 years old; having a study coupon;
and being able to provide written informed consent.
Effective access to any type of HIV-related health ser-
vice was the primary outcome. It was defined as at least
one office visit, or program enrollment reported by
participant in any of the HIV health services available
in Peru (public, social security, armed forces services
and private services) in the last 12 months, and it was
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access).Sample size
Sample size was calculated using the Epi Info 6.0v pack-
age (CDC, Atlanta, GA). As no previous data on health
care access among PLHA was available in the country,
we used a conservative approach estimating access in
50%, onsidering a margin of error of ± 5%; and a design
effect = 2 [20]. A total sample size of 800 individuals was
calculated.Study variables, data collection
The survey explored socio-demographic characteristics
including age, sexual and gender identity and education).
Household welfare (i.e. classifying households in socio-
economic strata) was measured through a scale devel-
oped by the Ministry of Finance (National Household
Targeting System - SISFOH scale) to identify households
in poverty and extreme poverty, and define targets for
social programs. Members’ characteristics, overcrowding
and possession of specific goods (e.g. home appliances)
were assigned a specific weight, so that the sum of all
weighted criteria determined the final household welfare
status indicator. Specific socio-economic classifications
for each city of the study were generated using differen-
tial weights, in order to account for regional variations
as proposed by the Peruvian Ministry of Finance [21].
Economic activity, general expenses, use of HIV-related
health services including ARV treatment, health-related
out-of-pocket expenses, and participation in GFATM-
sponsored microenterprise projects (specific interven-
tions promoted by the GFATM programs to improve the
living conditions of PLHA). This study did not focus on
clinical aspects of the management of HIV, since those
were beyond its scope.
A previous version of the instrument had been used in
other studies targeting a similar population at health fa-
cilities [13,22].Study procedures
Study staff explained the study process to eligible partici-
pants and obtained written consent before the face-to-
face interview. Participants who completed the interview
received S/. 20(approximately US $7). Participants were
invited to recruit three acquaintances living with HIV,
and older than 18 years. As incentive, for each referred
person who was successfully recruited each participant
received a raffle ticket for a scholarship to participate in a
six-month technical course, to be selected by the partici-
pant that won the raffle.Data analysis
Central tendency and dispersion measures [mean, stand-
ard deviation (SD), median, and interquartile range (IQR)]
were computed for continuous variables (age and out-of-
pocket expenses) to describe the study population, and
absolute and relative frequencies were computed for
categorical, nominal and ordinal variables. Naïve and
RDS-adjusted estimates were computed. For the latter, we
used the inverse of the individual’s reported social network
size as weight to compute RDS-adjusted estimates
(approach known as RDS II estimation) [23,24]. This
approach enables to weigh down the contribution of par-
ticipants who belong to bigger personal networks, and
thus are more likely to be enrolled in the study, and on
the contrary weighs up the contribution of those with
smaller social networks. It does not take into account
homophily (i.e the fact that people with a certain charac-
teristic recruit their equals), as the traditional method does
(i.e. approach known as RDS I estimation) [25].
To test the association between the hypothesized pre-
dictors and access to any type of HIV-related health
service, we used the chi square test (or Fisher exact test
when appropriate). Predictor variables under study in-
cluded: biological sex, sexual/gender identity, age (dichoto-
mized as ≤ 35 and > 35 years old), geographic region,
educational attainment, marital status, being the head of a
household, insurance and type of insurance, employment,
and household welfare. For all statistical analyses, a p-value
< 0.05 was considered to reject the null hypothesis and
claim statistically significant differences. All analyses were
conducted using the STATA v10 software.
Tables of results show both crude estimates and
corrected RDS II estimates (as indicated in table
headings).
Regulatory and ethical aspects
Ethical approval for the overall study execution, its
protocol and instruments was granted by the Cayetano
Heredia University Institutional Review Board (Lima,
Peru). After volunteering to enroll, all potential partici-
pants received a detailed explanation about the study
goals, procedures and associated risks. Those who were
willing to participate signed the informed consent form.
After this, trained field staff used structured question-
naires to interview the participants. Interviews were
conducted in private environments used solely for the pur-
pose of the interview, ensuring privacy and confidentiality.
Findings
Between September 2008 and January 2009, 863 individ-
uals who were members of the social networks of initial
recruiters (seeds) from PLHA organizations in the cities
of Lima/Callao, Chiclayo, Arequipa and Iquitos, were
enrolled.
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As shown in Table 1, the study population (N = 863) was
mainly composed by young adults (age mean = 35 years,
standard deviation = 9, age median = 35, interquartile
range = 29–41, range = 18–62), and mostly male (62%).
Self-reported sexual identity was: 25% gay, 11% bisexual,Table 1 Socio-demographic characteristics of PLHA
participants, Peru, 2008 (N = 863)





Male 533 (61.8%) 63.1
Female 330 (38.2%) 36.9
Identity (self-assigned)
Gay 217 (25.1%) 20.9
Transgender 29 (3.4%) 3.4
Bisexual 96 (11.1%) 11.2
Heterosexual 519 (60.1%) 64.0
Lesbian 2 (0.3%) 0.6
Age
18–35 years old 464 (53.8%) 58.6
Older than 35 years old 399 (46.2%) 41.4
Range 18–62
Median and interquartile range 35 (28–41)
Mean and standard deviation 35 (9)
Geographic area
Lima & Callao (Coast) 481 (55.7%) 30.9
Lambayeque (Northern Coast) 134 (15.5%) 15.6
Arequipa (Southern Highlands) 135 (15.7%) 27.5
Iquitos (Amazonia) 113 (13.1%) 26.0
Educational attainment
None to some Elementary School 47 (5.5%) 7.7
Full Elementary School to some High
School
224 (26.0%) 32.8
Full High School 295 (34.1%) 28.8
University or Technical 297 (34.4%) 30.7
Marital status
Single 491 (56.9%) 52.7
Married 75 (8.7%) 11.9
Domestic partner 178 (20.6%) 20.4
Divorced 64 (7.4%) 8.3
Widowed 55 (6.4%) 6.8
Year of HIV diagnosis
Before 2000 89 (10.3%) 6.5
2000–2002 117 (13.6%) 9.7
2003–2005 250 (29.0%) 22.2
2006–2008 407 (47.1%) 61.63% transgender and 60% heterosexual. 56% came from
Lima-Callao, 15% from Chiclayo, 16% from Arequipa and
13% from Iquitos. Thirty-one percent had completed elem-
entary school, 34% had completed high school and 34%
had at least some higher education. The majority of the
population (57%) was single, followed by those living with a
domestic partner (21%), and married (9%). Of those cur-
rently working (61%), only 18% had a job that included so-
cial benefits. Median of monthly income was S/.550 (About
USD 200), and IQR was S/. 300 to 800 (about 100.00 to
300.00 USD). Of those not currently working, 38% had
searched for a job in the past 7 days.
Regarding health care entitlements, 30% were entitled to
care paid by the limited-liability, government-sponsored
SIS (Comprehensive Health Insurance, mainly offered to
people in extreme poverty and for maternal and child care),
16% had Social Security affiliation (i.e. “EsSalud”, linked to
a longer-standing health provision system for formal
employees), 3% were entitled to other systems, and 52%
had no insurance at all. In the overall study population,
62% were diagnosed with HIV infection between the
years 2006–2008, 22% between 2003–2005, 10% between
2000–2002, and 6% before the year 2000 (see Table 1).
According to the official scale for classification of house-
hold welfare, 1% of the study population lived in extreme
poverty, 20% in poverty, and 78% were not poor (see
Table 2).Access to HIV care
Most (96%) of PLHA participating in the study reported
they had access to some kind of HIV-related health ser-
vice, and 84% that they were receiving those services
from a MoH facility (see Table 3). Approximately 77% of
those reporting access to care were receiving ARV treat-
ment, and 22% of those who were not in treatment
already had indication to start treatment. 27% percent
of those currently on ARV treatment reported out-of-
pocket expenses within the last month. Treatment
coverage varied according to year of diagnosis: of those
diagnosed before 2000, 97% were receiving ARV treat-
ment, while figures were 92%, 92% and 76% for partici-
pants diagnosed between 2000–2002, 2003–2005, and
2006–2008, respectively.
Table 4 shows the results of bivariate analysis of heath
care access and hypothesized determinants. Age younger
than 35 and transgender (male to female) identity were
associated with lower access to care (p <0.05).Coverage by health insurance and source of HIV care
The distribution of participants according to their en-
titlement to health provision systems and the current
provider of HIV care services is shown in Table 5.
Approximately 40% of interviewees covered by health
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security, Police and armed forces, and private providers)
received HIV services at MoH facilities. This group
represented 8% (51/679) of all individuals in the sample
who received HIV care at the MoH.
Discussion
In this study, health care access (as reported by partici-
pants) was assessed through estimating the proportion
of the population receiving HIV health care from any
type of provider and came to be close to 96% across 4
Peruvian cities. This high coverage might be explained
by the fact that ARVT provision is free of cost as part of
public policy of the Peruvian Ministry of Health. People
with an HIV diagnosis who want to receive treatment
and care at public hospitals, or at local NGOs that have
received accreditation from the Ministry of Health, have
to be enrolled in the ARVT program for follow-up in
order to start on medication promptly when needed.
The National Social Security System (ESSALUD) pro-
vides services to those on an employment payroll and
private services for people that will pay for them. All
public and private health services have to comply with
standards established by the Ministry of Health. As re-
sults show, the majority of people receive treatment and
care from public hospitals (83%), followed by social se-
curity health facilities (9%). An initial need to reach a
somewhat overestimated coverage target in 2005–2006,
led the MoH to actively search for cases [12]. It also
could be hypothesized that, since the establishment of
the ARVT Program as a free-of-cost strategy, access to
health services may have increased among PLHA in
order to receive ARVT when needed.
Lower access to HIV/AIDS services was associated
with transgender (male to female) identity and being












Extreme poverty SISFOH1 0 (0.0%) 0





SISFOH3 16 (2.6%) 5.3
SISFOH4 28 (4.5%) 5.8




Not in poverty SISFOH6 76 (12.4%) 16.5
SISFOH7 444 (72.2%) 59.2
Total above
poverty line
520 (84.6) 75.7group confirmed transgender people as the most vulner-
able population to HIV in Peru, with a prevalence of
30%, more than doubling the figures observed among
MSM [26]. This population experiences very specific
conditions of exclusion and marginalization that partly
explain their vulnerability not only by means of lower
access to health care but also to education and justice.
This is supported by studies that show that transgender
women report more difficulties when dealing with health
providers than men who have sex with men and sex
workers [12]. Despite progress in quality of care for
transgender people, stigma around both HIV and gender
identity, together with concerns about confidentiality
(i.e. being seen by their peers, particularly if involved in
sex work), or difficulties in keeping up with medical pre-
scriptions and treatment pick-up times, play a role in
both lower access and treatment attrition [27]. These
key elements should be taken into account to resolve
this serious access issue.
The association between age younger than 35 y.o. and
lower access is less clear and requires further study.
Likely explanations are, however, the well-known resist-
ance of younger people to use health care, and issues
regarding education and income [28], where potentially
lower economic resources to afford out-of-pocket ex-
penses could act as a barrier to start HIV care. Likewise,
issues such as lower family responsibilities and poten-
tially a better health status (i.e. earlier infection stages)
might explain this difference. Further explanation of this
finding should guide specific interventions to improve
access in this age group.
The majority of PLHA who report access to HIV care
in the study are already receiving ARVT. Since all these
people are already being seen by health providers the es-
timate becomes a measure of Program effectiveness. The
















0 (0.0%) 0 0 (0.0%) 0
0 (0.0%) 0 8 (7.1%) 6.3
7 (5.2%) 9.1 8 (7.1%) 5.9
9 (6.7%) 6.3 19 (16.8%) 16.1
23 (17.0%) 13.7 20 (17.7%) 17.5
39 (28.9) 29.1 47 (48.7) 45.8
15 (11.1%) 11.8 12 (10.6%) 10.8
81 (60.0%) 59.1 46 (40.7%) 43.4
96 (71.1) 70.9 58 (51.3) 54.2
Table 3 Characteristics of health care access and out-of-pocket expenses reported by PLHA participants, Peru,
2008 (N = 863)
Characteristics and categories Crude estimate Adjusted estimate (RDS-II)
Currently receiving any HIV-related health service (medical check-ups, laboratory testing,
or ARV treatment) (N = 863)
832 (96.4%) 95.6%
Institution/Program were PLHA participant receives HIV care (N = 827/832)
Public (Ministry of Health) Hospital 653 (79.0%) 82.5%
Public Non-Hospital Health facility 26 (3.1%) 1.5%
Social Security Health facility (EsSalud) 73 (8.8%) 9.0%
Police and Armed Forces Health facility 14 (1.7%) 2.2%
Non-governmental organizations 52 (6.3%) 4.3%
Religious institutions 9 (1.1%) 0.5%
Currently receiving ARV treatment (N = 830/832) 703 (84.7%) 76.8%
Year ARV treatment was started (N = 700/703)
Before 2000 12 (1.7%) 1.7%
2000–2002 36 (5.2%) 3.1%
2003–2005 234 (33.4%) 22.9%
2006–2008 418 (59.7%) 72.3%
If not currently receiving ARV, PLHA received indication to start ARV (N = 123/127) 21 (17.1%) 21.6%
If currently receiving ARV treatment, any reported HIV-related out-of-pocket expenses within
the last month (N = 697/703)
238 (36.0%) 26.7%
Reported HIV-related out-of-pocket expenses within last month (N = 218/238)
(Median, range and interquartile range, in nuevos soles)
50 (8 – 7,500; 25–80).
If currently receiving ARV treatment, any reported out-of-pocket expenses for laboratory testing
(Only those who started ARV between 2006–2008, N = 417/418)
411 (98.6%) 99.1%
Reported out-of-pocket expenses for laboratory testing (Only those who started ARV
between 2006–2008, N = 297/418) (Median, range and interquartile range, in nuevos soles)
100 (10–3000; 60–80)
Any reported not HIV-related out-of-pocket expenses within the last month for office visits,
laboratory testing or medications not prescribed for HIV/AIDS (N = 863)
267 (30.9%) 27.1%
Reported not HIV-related out-of-pocket expenses within the last month (N = 246/267)
(Median, range and interquartile range, in nuevos soles)
50 (4–2500; 25–150)
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vian cities in 2008 [15], and this consistency could be
interpreted as a performance parameter of the Peruvian
HAART Program (i.e. approximately a fifth of PLHA
registered in the Program and with ARV indication are
waiting to start therapy at a given point in time). Since
numbers were small, it becomes difficult to further ex-
plore whether certain groups of PLHA were more likely
to experience delayed access to treatment, and such
issue remains a topic for further research. The delay
might be explained by a shortage of medication supply
in health facilities [29], or by a delay due to other steps
in the process, such as completion of all laboratory test-
ing needed, which in many hospitals is financed out-of
-pocket. Shortage of ARV medication for PLHA has
been described as one of the major problems encoun-
tered by users of HIV/AIDS public services [30] and is
one of the most important challenges the public sector
has to face in the next years. Additionally the nationalguidelines for ARV provision, updated in July 2012 in
line with WHO recommendations [31], indicate that
ARVT should be provided to all people living with HIV
with CD4 counts below 350 cells/mm3, while the previ-
ous cut-off point was CD4 < 200. This change will neces-
sarily increase the number of people with indication of
treatment. The fact that 76% of those diagnosed with
HIV between 2006 and 2008 were receiving ARV ther-
apy by the time the study was conducted (2009) could
indicate a high proportion of late HIV diagnosis, al-
though this topic was not explored in our survey and
could not be corroborated with official information from
the public health system. Nonetheless, there is evidence
of a sustained decrease in HIV mortality since the start
of the National HAART Program [32].
An assessment of effective HIV-care provider vs. gen-
eral health care provider entitlement showed that one
third of PLHA covered by non-public health insurance
used MoH HIV services (which are in fact open to all).
Table 4 Lack of HIV-related health care access according to key characteristics of PLHA participants, Peru,
2008 (N = 863)
Characteristics and categories Crude estimate Adjusted estimate (RDS-II) P value
Biological sex Male 22 (4.1%) 5.2 0.30
Female 8 (2.7%) 2.9
Sexual/Gender Identity Homosexual/Gay 5 (2.3%) 2.7 <0.05
Transgender 6 (20.7%) 27.3
Bisexual 3 (3.1%) 2.7
Heterosexual 17 (3.2%) 3.8
Age Range 35 years old or younger 24 (5.2%) 6.2 <0.05
Older than 35 years old 7 (1.7%) 1.7
Geographic area Coast (Lima-Callao and Chiclayo) 20 (3.2%) 3.0 0.27
Andes (Arequipa) 7 (5.2%) 4.7
Amazonia (Iquitos) 4 (3.5%) 0.9
Educational attainment None/Some Elementary School 0 (0.0%) 0 0.33
Completed elementary school 11 (4.9%) 7.1
Completed High School 10 (3.4%) 3.2
Some higher education 10 (3.4%) 3.6
Marital status Single 21 (4.3%) 4.5 0.57
Married 2 (2.7%) 8.3
Domestic partner 5 (2.8%) 3.6
Divorced/Separated 2 (3.1%) 1.5
Widowed 1 (1.8%) 1.9
Head of household Yes 12 (3.6%) 4.4 0.96
No 19 (3.6%) 4.3
Health insurance Social Security, Forces, Private 4 (2.7%) 1.9 0.80
SIS (Ministry of Health) 7 (3.2%) 5.4
No insurance 20 (4.0%) 4.6
Currently working Yes 18 (3.4%) 5.1 0.37
No 13 (3.8%) 3.3
Poverty Extreme poverty 0 (0.0%) 0 0.13
Moderate poverty 14 (7.7%) 8.0
Not in poverty 17 (2.5%) 3.0
Table 5 PLHA participants distributed according to Institution or Program where HIV services are received and type of
health insurance, Peru, 2008 (N = 827/832)
Entitlement to specific health
provision regimes among People
living with HIV
Institution or Program where PLHA participants receive HIV care
Social Security, Police and
Armed Forces, and Private
















Social Security, Police and Armed
Forces, and Private
84 (57.9%) 56.6% 51 (35.2%) 40.0% 10 (6.9%) 3.4%
Ministry of Health (SIS) 0 (0.0%) 0.0% 196 (92.9%) 95.7% 15 (7.1%) 4.3%
No insurance 3 (0.6%) 1.5% 432 (91.7%) 93.0% 36 (7.7%) 5.5%
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care recipients. This unnoticed and silent transfer of
users from various programs to the public system is evi-
dence of a cross-subsidy. In part, such transfer was even
promoted by the MoH at the time of inception of the
treatment program, when it was still funded by the
GFATM and the targets set up were too high, as a result
of inaccurate estimation of the number of potential users
[9,33]. At this point, however, specific health insurance
systems should pay for the ARV treatment of PLHA
who are entitled to their services, and leave the public
system for those not covered. Additionally, enrollment
in ARVT should be friendly and simple regardless of the
provider. For example, accessing ARVT through the
Social Security system is still more complex since a
small co-payment by employers and time-consuming
paperwork by the patients are still needed.
Poverty has been described as a barrier because of its
impact on how people perceive and express needs, partly
due to competing subsistence demands and cost barriers
to accessing services [2,34,35]. Previous studies provide
evidence of the relationship between poverty and health
care access in Peru. In general, families reporting lower
income and structural constraints (e.g. lack of basic ser-
vices) have the lowest levels of health care access [36].
In other countries, the fact that PLHAs of lower socio-
economic status are more likely to start ARVT later and
exhibit shorter survival than PLHA of higher socio-
economic status has already been recognized [37]. In
our study, however, poverty was not associated with
lower access to health services when we corrected for
RDS II analysis (although it was in unadjusted esti-
mates), in part probably because of the small numbers of
those who lacked such access and the lower frequency
of poverty. This potential relationship should be further
explored, particularly given the HIV program’s invest-
ment in micro-enterprise interventions for economic
empowerment of PLHA [16].
Limitations
Among the limitations of this study, it is difficult to es-
tablish if PLHA form a social network based on the fact
of being HIV positive. Some PLHA community groups
exist where members interact among themselves, often
across divisions of gender and sexual orientation, but
this does not imply that, overall, every person with HIV
will form a network and interact as a group. However,
we used RDS in four metropolitan areas of Peru and
succeeded in obtaining a broader sample, apparently
more representative concerning PLHA gender compos-
ition, source of HIV/AIDS care, and sexual orientation,
compared to other surveys [12-15]. Nevertheless, it is
possible that this recruitment approach more efficiently
reached networks of people who are closer to CBOs andactivists who have more access to information and to
health services, hence still over-estimating access among
PLHA. Additionally, our limited focus on clinical indica-
tors of the present and past health status of participants
may have affected our understanding of other barriers to
health care access, for example, advanced disease and in-
ability to mobilize to seek care.
Conclusion
This is the first study of access to care among PLHA in
Peru using RDS, and also the first study conducted
through a sampling approach other than convenience re-
cruitment. On a sample of 863 PLHA from 4 cities, it
found that most PLHA (96%) reported access to some
kind of HIV-related health service, and 85% of them
were already receiving ARVT, and only 17% of those not
in treatment had an indication to start ARVT. Trans-
gender identity and age younger than 35 years old, but
not poverty, were associated with lower access to health
care. Finally, 40% of interviewees covered by health in-
surance other than the Ministry of Health received HIV
services at MoH facilities, and represented 8% of the
population effectively receiving HIV care from the MoH.
Our findings contribute to a better social and demo-
graphic characterization of the situation of PLHAs, their
access to HIV care and their source of care, and provide
an assessment of equity in access. In the long term, it is
expected that HIV care access, as well as its social deter-
minants, will impact on the morbidity and mortality
rates among those affected by the HIV/AIDS epidemic.
HIV care providers and program managers should fur-
ther characterize these barriers and develop strategies to
resolve them by means of policy change, for the benefit
of the health service users and as part of the national
response to the HIV/AIDS epidemic within a human
rights framework.
Competing interests
The authors declared that they have no competing interest.
Authors’ contributions
ASS contributed to study design, implementation, analysis (including the
RDS approach) and writing. ERS contributed to study design, analysis and
writing. CS contributed to writing of the first report. MG contributed to study
design and implementation. MP contributed to the adaptation of the SES
scale. CFC contributed to study design, analysis, write-up and final editing.
All authors read and approved the final manuscript.
Acknowledgements
This study was supported in part by a grant from HEARD (University of Kwa
Zulu Natal) and IDRC, and by the Alliance for Health Policy and Systems
Research. We would like to acknowledge the crucial support of organizations
of PLHA across the country which collaborated to the implementation of
this study. We also acknowledge support from Miguel Ceccarelli in helping
with the preparation of parts of this manuscript.
Received: 11 September 2012 Accepted: 10 May 2013
Published: 17 May 2013
Silva-Santisteban et al. Globalization and Health 2013, 9:22 Page 9 of 9
http://www.globalizationandhealth.com/content/9/1/22References
1. Commission on Social Determinants of Health (CSDH): Closing the gap in a
generation: health equity through action on the social determinants of health,
Final report of the Commission on Social Determinants of Health. Geneva:
WHO; 2008.
2. WHO: Monitoring Equity in Access to AIDS treatment programmes: a review of
concepts, models, methods and indicators, Commissioned by the World
Health Organization (Department of Ethics, Equity, Trade and Human Rights
- Social Determinants of Health) and the Regional Network for Equity in
Health in East and Southern Africa (EQUINET) through REACH Trust and
Training and Research Support Centre (TARSC). Geneva: WHO; 2010.
3. Steele CB, Meléndez-Morales L, Campoluci R, DeLuca N, Dean HD: Health
disparities in HIV/AIDS, viral hepatitis, sexually transmitted diseases, and
tuberculosis in the United States: issues, burden, and response, A
retrospective review, 2000–2004. Atlanta: Centers for Disease Control
and Prevention (US); 2007.
4. Blas E, SivasankaraKurup A (Eds): Equity, social determinants and public health
programmes. WHO: Geneva; 2010.
5. Beltran VM, Harrison KM, Hall HI, Dean HD: Collection of social determinant of
health measures in U.S. national surveillance systems for HIV, viral hepatitis,
STDs, and TB. PublicHealth Rep 2011, 126(Suppl 3):41–53.
6. Arrivillaga M: Social determinants and adherence to treatment among
Colombian women living with HIV/AIDS. Int J EquityHealth 2012,
11(Suppl 1):A1.
7. United Nations General Assembly: Declaration of Commitment on HIV/AIDS.
United Nations General Assembly Session on HIV/AIDS 25-25 June 2001. ; 2001.
http://data.unaids.org/publications/irc-pub03/aidsdeclaration_en.pdf.
8. United Nations General Assembly: Progress made in the implementation of
the Declaration of Commitment on HIV/AIDS and the Political Declaration on
HIV/AIDS. UNGASS: Report of the Secretary-General; 2010.
9. Caceres CF, Mendoza W: The national response to the HIV/AIDS epidemic
in Peru: accomplishments and gaps–a review. J Acquir Immune Defic Syndr
2009, 51(Suppl 1):S60–S66.
10. Ministerio de Salud: Analisis de la situación epidemiologica del VIH/SIDA en el
Perú. Lima, Perú: Direccion General de Epidemiologia-Ministerio de Salud
del Perú; 2006.
11. Peruvian Ministry of Health: Peruvian National report about the developed
progress on the implemention of the UNGASS (January 2008- December 2009).
Lima, Peru: MINSA; 2010.
12. Caceres CF, Giron JM, Sandoval C, Lopez R, et al: Implementation effects of
GFATM-supported HIV/AIDS projects on the health sector, civil society
and affected communities in Peru 2004-2007. Glob Public Health 2010,
5(3):247–265.
13. Perú-Universidad Peruana Cayetano Heredia CARE: Estudio de medición de
línea de base de los objetivos 1-4 del componente VIH del Programa: Cerrando
brechas hacia el logro de los objetivos del milenio en TBC y VIH/SIDA en el
Perú. Propuesta con enfoque de descentralización multisectorial participativa
(Informe Final). Lima, Peru: CARE-Perú/UPCH; 2007.
14. Perú-Universidad Peruana Cayetano Heredia CARE: Estudio de tercera
medición de los indicadores de los Objetivos 2-4 del Componente VIH del
Programa Fortalecimiento del Control del SIDA y la Tuberculosis en el Perú
(Informe Final). Lima, Perú: CARE-Perú/UPCH; 2007.
15. Perú-Universidad Peruana Cayetano Heredia CARE: Estudio final de evaluación del
componente VIH del Programa Fortalecimiento del Control del SIDA y la Tuberculosis
en el Perú (Informe Final). Lima, Perú: CARE-Perú/UPCH; 2009.
16. Perú-Universidad Peruana Cayetano Heredia CARE: Informe de Medición de
indicadores y evaluación final. Programa en VIH de V Ronda(Informe final).
Lima, Perú: CARE-Perú/UPCH; 2012.
17. Malekinejad M, Johnston LG, Kendall C, et al: Using respondent-driven
sampling methodology for HIV biological and behavioral surveillance in
international settings: a systematic review. AIDS Behav 2008,
12(Suppl 1):S105–S130.
18. Bravo P, Edwards A, Rollnick S, Elwyn G: Tough decisions faced by people
living with HIV: a literature review of psychosocial problems. AIDS Rev
2010, 12(2):76–88.
19. Heckathorn DD: Respondent-driven dampling: a new approach to the
study of hidden populations. Soc Probl 1997, 44(2):174–199.
20. Salganik MJ: Variance estimation, design effects, and sample size
calculations for respondent-driven sampling. J UrbanHealth. 2006,
83(Suppl 1):i98–i112.21. Ministerio de Economia y Finazas: Propuesta metodologica para identificar a
los potenciales beneficiarios de los programas sociales en el Peru. Lima, Perú:
Ministerio de Economía y Finanzas; 2009.
22. Giron JM, Segura ER, Salazar V, et al: Percepciones de las personas viviendo con
VIH/SIDA sobre los servicios de salud y el tratamiento antiretroviral de gran
actividad: Un estudio transversal en cinco ciudades del Peru. Rev Peru Med Exp
SaludPublica 2007, 24(3):211–217. Retrieved from http://www.scielo.org.pe/pdf/
rins/v224n213/a203v224n213.pdf.
23. Goel S, Salganik MJ: Respondent-driven sampling as Markov chain Monte
Carlo. Stat Med 2009, 28(17):2202–2229.
24. Volz E, Heckathorn DD: Probability based estimation theory for
respondent-driven sampling. J Off Stat 2008, 24(1):79–97. Retrieved from.
25. Salganik MJ, Heckathorn DD: Sampling and estimation in hidden
populations using respondent-driven sampling. Sociol Methodol 2004,
34(1):193–239.
26. Silva-Santisteban A, Salazar X, Villayzan J, Caceres CF: Understanding the
HIV/AIDS epidemic in the male to female transgender population of
lima, Peru: results from a sero-epidemiologic study using respondent-
driven sampling. AIDS Behav 2012, 16(4):872–881.
27. Salazar X, Villayzán J, Silva Santisteban A, Cáceres CF: Las personas trans y la
epidemia del VIH/sida en el Perú: aspectos sociales y epidemiológicos. Lima:
IESSDEH, UPCH, ONUSIDA, amFAR; 2010.
28. Solar O, Irwin A: A conceptual framework for action on the social
determinants of health, Social Determinants of Health Discussion Paper
Series 2. Geneva: World Health Organization; 2010. Monitoring Equity in
Access to AIDS treatment programmes: A review of concepts, models, methods
and indicators. World Health Organization.
29. Echevarria J, Lopez de Castilla D, Seas C, Verdonck K, Gotuzzo E: Scaling-up
highly active antiretroviral therapy (HAART) in Peru: problems on the
horizon. J Acquir Immune Defic Syndr 2006, 43(5):625–626.
30. Ministerio de Salud: Informe Nacional sobre los progresos realizados en VIH en
el país – Período 2010-2011 (UNGASS). Lima; 2012.
31. Ministerio de Salud: Norma Técnica de Salud sobre Atención Integral a
Personas con VIH N° 097-MINSA/DGSP-V.01. Lima, Peru: MINSA; 2012.
32. Ministerio de Salud: Análisis de la mortalidad por causas especificas: VIH/SIDA,
tuberculosis, causas maternas y Accidentes de transito. 2007-2008. Lima,
Peru: MINSA; 2011.
33. Ministerio de Salud-Universidad Peruana Cayetano Heredia:
Recommendations on the implementation of an HIV/AIDS antiretroviral
therapy program in Peru. Lima, Peru: MINSA/UPCH; 2004.
34. Cunningham WE, et al: The impact of competing subsistence needs and
barriers on access to medical care for persons with human
immunodeficiency virus receiving care in the United States. Medical Care.
1999, 37(12):1270–1281.
35. Lonnroth, et al: Tuberculosis: the role of risk factors and social determinants. In:
Blas E and SivasankaraKurup A, eds. Equity, social determinants and public
health programmes. Geneva: WHO; 2010.
36. Instituto Nacional de Estadistica e Informatica: Determinantes del acceso a
los servicios de salud en el Peru. Lima, Peru: INEI [Online]; 2000. Available:
http://www.inei.gob.pe/biblioineipub/bancopub/Est/Lib0387/PRESENTA.htm
[Accesed: September 20th 2009].
37. Joy R, Druyts EF, Brandson EK, Lima VD, et al: Impact of neighborhood-
level socioeconomic status on HIV disease progression in a universal
health care setting. J Acquir Immune Defic Syndr 2008, 47(4):500–505.
doi:10.1186/1744-8603-9-22
Cite this article as: Silva-Santisteban et al.: Determinants of unequal HIV
care access among people living with HIV in Peru. Globalization and
Health 2013 9:22.
